Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2022-05-31 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
(I) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2021, THE SECOND A SHARES CLASS MEETING OF 2022 AND THE SECOND H SHARES CLASS MEETING OF 2022 HELD ON MAY 31, 2022&#x3b; AND (II) 2021 PROFIT DISTRIBU
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results of the Annual General Meeting (AGM) of 2021, the Second A Shares Class Meeting of 2022, and the Second H Shares Class Meeting of 2022 held on May 31, 2022. It details the voting outcomes on various resolutions including the 2021 Profit Distribution Plan and other corporate matters. The text includes detailed voting percentages and confirms the passing of ordinary and special resolutions. It also announces the 2021 Profit Distribution Plan with dividend details. The document is not the full annual report or financial statements but an official announcement of voting results and dividend declaration following the AGM and class meetings. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA).
2022-05-31 English
ANNOUNCEMENT ON THE FINAL NUMBER OF ADDITIONAL CONVERSION SHARES TO BE ISSUED UNDER THE CONVERTIBLE BONDS-RELATED SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding the final number of additional conversion shares to be issued under a convertible bonds-related specific mandate. It references previous announcements and circulars, discusses adjustments to conversion prices and share numbers, and mentions the upcoming AGM where the mandate will be sought. The document is relatively short (3460 characters) and primarily provides an update on financing-related share issuance tied to convertible bonds. It does not contain full financial statements or detailed financial analysis, nor is it a transcript, report, or voting result. The content fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure and issuance of shares under convertible bonds.
2022-05-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-05-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-05-26 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-05-26 English
UPDATES ON THE ARRANGEMENTS OF THE ANNUAL GENERAL MEETING AND H SHARE CLASS MEETING TO BE HELD ON MAY 31, 2022
AGM Information Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding updates on the arrangements for the Annual General Meeting (AGM) and H Share Class Meeting scheduled for May 31, 2022. It discusses changes in venue, options for shareholders to attend via live webcast, proxy voting instructions, and COVID-19 related precautions. The document does not contain financial statements, detailed financial analysis, or results. It is primarily an informational announcement about the logistics and arrangements of the AGM and related meetings. It references the Circular, Notices, and Proxy Forms but does not include them or their contents. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including logistical updates and meeting arrangements.
2022-05-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.